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April 14, 2009:1339–42he Cardiorenal Syndrome
Classification Into 4 Groups?
he recent publication by Ronco et al. (1) provides a thorough
escription of the pathophysiology of the cardiorenal syndrome
CRS) and comes with a proposal for a new classification.
The innovative classification is based on the putative causative
athophysiological mechanism that underlies failure of the heart
nd kidneys. The classification focuses on 2 aspects of the process:
uration (acute onset vs. chronic disease), and the sequence of
vents (kidney failure first vs. heart failure first). For clinical
urposes, the distinction between acute and chronic CRS proposed
y the authors seems very useful: they propose a clinical syndrome
here acute heart failure (HF) leads to acute kidney injury (AKI)
type 1) and vice versa (AKI leading to acute HF; type 3). This
eems relevant, because both conditions have a different pathogen-
sis and require a different clinical approach. However, the
istinction between CRS type 2 (chronic HF leading to progres-
ive chronic kidney disease [CKD]) and CRS type 4 (CKD leading
o chronic HF and increased risk of cardiovascular events) is based
n the assumption that, also in advanced and chronic disease, 2
ifferent pathophysiological mechanisms can be distinguished.
In the paper by Bongartz et al. (2), we postulate a model of
chronic) cardiorenal interactions, with a quite different philoso-
hy. In that model, we have searched for the common denomina-
ors in heart and renal failure (i.e., for similar pathophysiological
nteractions in “heart-kidney” and “kidney-heart” failure). We have
een able to identify 4 cardiorenal connectors: inflammation, nitric
xide/reactive oxygen species balance, the sympathetic nervous
ystem, and the renin-angiotensin system. In our view these
onnectors are, in addition to the well-known hemodynamic
nteractions between heart and kidney, responsible for the strongly
rogressive nature of the disease process, because they evoke
ositive feedback mechanisms. Therefore, the sequence in which
he 2 conditions arise is not important.
Furthermore, we question the feasibility of the distinction
etween CRS type 2 and 4 in terms of diagnosis. In addition, both
roups are similar in terms of management, because they both
hould receive optimal interventions to block the interaction
etween the cardiorenal connectors, in addition to the specific
easures that apply to chronic HF and CKD.
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e are pleased to see that our recent paper (1) on cardiorenal
yndrome (CRS) has captured the attention of many investigators,
emonstrating the importance of this subject. We have received
everal positive comments on the structured classification/
efinition of the CRS that we have proposed. In their letter, Dr.
an der Putten and colleagues raise an important point about the
idirectional nature of chronic heart-kidney interactions and ques-
ion the wisdom of categorizing these into chronic “cardio-renal”
CRS 2) versus chronic “reno-cardiac” (CRS 4) syndromes. They
efer to a report by Bongartz et al. (2), who show that common
athophysiology leads to a chronic state of positive feedback
eading to progression of both heart and kidney disease. Indeed,
his article is a “must read” for anyone with an interest in this
isorder, because it highlights a number of important mechanisms
hat perpetuate and amplify structural and functional derangement,
eyond simple hemodynamics.
We agree with Dr. van der Putten and colleagues that the
equence in which chronic heart-kidney conditions arise might not
e of paramount clinical importance, because management strat-
gies need to address interruption of these positive feedback loops
here possible. However, we also posit that a categorization
cheme serves an important role in terms of designing epidemio-
ogical studies, identifying target populations for intervention,
eveloping targeted diagnostic tools, studying the prevention and
anagement of the syndromes, and promoting effective commu-
ication and collaboration among researchers and clinicians from
iffering disciplines. In response to these issues, a consensus
onference was recently held in Venice, Italy in September 2008
nder the auspices of the Acute Dialysis Quality Initiative
ADQI), bringing together key opinion leaders and experts in the
elds of nephrology, critical care, cardiac surgery, cardiology, and
pidemiology. At this conference, a consensus definition and
lassification system for the CRS was reached with the 5 subtypes
roposed in our review. The ADQI working group recognized that
any patients might populate or move between subtypes during
he course of their disease, and indeed it might not always be
ossible to categorize a patient as CRS type 2 or 4. However, the
lassification is a work in progress, and feedback from interested
roups such as Dr. van der Putten and colleagues will be important
or future refinements and iterations.
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